Prevalence of patients with indication of genetic evaluation for hereditary breast and ovarian syndrome in the Brazilian cohort study – AMAZONA III – LACOG

19/05/2020

Abstracts, Publications, Publications Breast

Prevalence of patients with indication of genetic evaluation for hereditary breast and ovarian syndrome in the Brazilian cohort study – AMAZONA III

Alessandra Borba Anton de Souza, Daniela Rosa, Antonio LuiZ Frasson, Felipe Pereira Zerwes, Nathalia Cunha Rossato, Patricia Asthon-Prolla, Sergio Simon, Jose Bines, Carlos Barrios, Alessandra Morelle, Carlos Alberto Sampaio Filho, Max Mano, Rafaela Gomes and Gustavo Werutsky.

SABCS 2019; P2-09-11, poster

Full link: https://www.abstractsonline.com/pp8/#!/7946/presentation/701

Prevalence of patients with indication of genetic evaluation for hereditary breast and ovarian syndrome in the Brazilian cohort study – AMAZONA III

Send us a message

Cura Project

Prevalence of patients with indication of genetic evaluation for hereditary breast and ovarian syndrome in the Brazilian cohort study – AMAZONA III

Related Posts

ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor-Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy

Comprehensive genomic profiling of non-small cell lung cancer in Brazil (GBOT 0118/LACOG 0418).

Cross-Cultural Validity Study of a Medical Education Leadership Competencies Instrument in Latin American Physicians: A Multinational Study

Advanced stage at diagnosis and worse clinicopathologic features in young woman with breast cancer. A sub-analysis of Brazilian population through the AMAZONA III study (GBECAM 0115).